to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.
New healthcare business plans can go wrong if the life science company founders don't discuss how they'll split up proceeds and shares of the company. Read what the Kauffman Foundation and other leaders suggest for life science entrepreneurs.
Venture funding is up, albeit slightly. To grab your slice of the capital pie, start thinking differently.
Two leading academics are out with a new book that says the key to making money for new business owners is this: your financial statements are your friends.
Young biotech companies sometimes face a valley of death in funding, but a venture capital researcher is challenging that idea. Read more about the early stage funding valley of death.
Local investing could be the answer to the problem of dealing with big banks and the way they do business. Read more about this funding alternative for startups.
Investors in bioscience are looking not just for financial returns, but societal returns over the long haul in a global economy. And that will take collaborative efforts and a crowdsourcing of expertise as well as capital.
Business conditions are tough for new healthcare businesses, but slivers of sunlight are shooting through the clouds. Take advantage by setting the stage for a small business loan.
Angel investors in the life sciences talk about when, why and how to seek angel funding for your pharmaceutical, mobile and medical device startups.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.